We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Constitutional CHEK2 mutations are associated with a decreased risk of lung and laryngeal cancers.
- Authors
Cezary Cybulski; Bartlomiej Masojc; Dorota Oszutowska; Ewa Jaworowska; Tomasz Grodzki; Piotr Waloszczyk; Piotr Serwatowski; Juliusz Pankowski; Tomasz Huzarski; Tomasz Byrski; Bohdan Górski; Anna Jakubowska; Tadeusz Debniak; Dominika Wokolorczyk; Jacek Gronwald; Czeslawa Tarnowska; Pablo Serrano-Fernández; Jan Lubinski; Steven A. Narod
- Abstract
Mutations in the CHEK2 gene have been associated with increased risks of breast, prostate and colon cancer. In contrast, a previous report suggests that individuals with the I157T missense variant of the CHEK2 gene might be at decreased risk of lung cancer and upper aero-digestive cancers. To confirm this hypothesis, we genotyped 895 cases of lung cancer, 430 cases of laryngeal cancer and 6391 controls from Poland for four founder alleles in the CHEK2 gene, each of which has been associated with an increased risk of cancer at several sites. The presence of a CHEK2 mutation was protective against both lung cancer [odds ratio (OR) = 0.3; 95% confidence interval (CI) 0.2–0.5; P = 3 × 10−8] and laryngeal cancer (OR = 0.6; 95% CI 0.3–0.99; P = 0.05). The basis of the protective effect is unknown, but may relate to the reduced viability of lung cancer cells with a CHEK2 mutation. Lung cancers frequently possess other defects in genes in the DNA damage response pathway (e.g. p53 mutations) and have a high level of genotoxic DNA damage induced by tobacco smoke. We speculate that lung cancer cells with impaired CHEK2 function undergo increased rates of cell death.
- Subjects
GENETIC mutation; GENES; LUNG cancer; CELL death
- Publication
Carcinogenesis, 2008, Vol 29, Issue 4, p762
- ISSN
0143-3334
- Publication type
Article
- DOI
10.1093/carcin/bgn044